Marlène Legrand

Laboratoire de Biophotonique et Pharmacologie

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Philippe Rondé

Université de Strasbourg

ÉS

Émilie Sick

Laboratoire de Biophotonique et Pharmacologie

Denis Dujardin

Laboratoire de Biophotonique et Pharmacologie

Antoine Mousson

Domain Therapeutics (France)

Jan De Mey

Ghent University Hospital

Romain Vauchelles

Université de Strasbourg

Philippe Carl

Université de Strasbourg

Tania Steffan

Université de Strasbourg

Jean‐Pierre Gies

Laboratoire de Biophotonique et Pharmacologie

Marta Fructuoso

Institut du Cerveau

Cooperative Institutions

Centre National de la Recherche Scientifique

Université de Strasbourg

Laboratoire de Biophotonique et Pharmacologie

Inserm

Pitié-Salpêtrière Hospital

Sorbonne Université

Université Paris Cité

École Supérieure de Biotechnologie de Strasbourg

Assistance Publique – Hôpitaux de Paris

Institut de génétique et de biologie moléculaire et cellulaire

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Inhibiting FAK–Paxillin Interaction Reduces Migration and Invadopodia-Mediated Matrix Degradation in Metastatic Melanoma Cells

Cancers (2021)

Antoine Mousson Marlène Legrand Tania Steffan Romain Vauchelles Philippe Carl

The nonreceptor tyrosine kinase FAK is a promising target for solid tumor treatment because it promotes invasion, tumor progression, and drug resistance when overexpressed. Investigating the role of FAK in human melanoma cells, we found that both in situ and metastatic melanoma cells strongly express FAK, where it controls tumor cells’ invasiveness by regulating focal adhesion-mediated cell motility. Inhibiting FAK in human metastatic melanoma cells with either siRNA or a small inhibitor targeting the kinase domain impaired migration but led to increased invadopodia formation and extracellular matrix degradation. Using FAK mutated at Y397, we found that this unexpected increase in invadopodia activity is due to the lack of phosphorylation at this residue. To preserve FAK–Src interaction while inhibiting pro-migratory functions of FAK, we found that altering FAK–paxillin interaction, with either FAK mutation in the focal adhesion targeting (FAT) domain or a competitive inhibitor peptide mimicking paxillin LD domains drastically reduces cell migration and matrix degradation by preserving FAK activity in the cytoplasm. In conclusion, our data show that targeting FAK–paxillin interactions could be a potential therapeutic strategy to prevent metastasis formation, and molecules targeting this interface could be alternative to inhibitors of FAK kinase activity which display unexpected effects.

Paxillin

Invadopodia

PTK2

Podosome

10.3390/cancers13081871

Cite

Citations (28)

Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TC

Journal of Hematology & Oncology (2022)

Ludovic Jondreville Maud D’Aveni Hélène Labussière‐Wallet Amandine Le Bourgeois Alban Villate

Abstract Since the emergence of the Omicron variant of SARS-CoV-2, though considered less virulent, hospitalization and death rates among immunocompromised patients remain high, especially for poor responders to vaccination. We conducted a retrospective multicentric study to evaluate pre-exposure prophylaxis with AZD7442 (tixagevimab/cilgavimab) for preventing COVID-19 in adult allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients. Among the 161 patients of our cohort, 22 (14%) contracted COVID-19 after a median follow-up of 105 days, but no severe form was observed. Only one major adverse event was reported: an acute coronary syndrome, resolved without sequelae. Pending randomized controlled trial results, our data support the use of AZD7442 as pre-exposure prophylaxis for COVID-19 during Omicron wave in allo-HSCT patients who failed to develop humoral immunity to vaccination, to prevent severe and potentially lethal forms of SARS-CoV-2 infection.

Hematology

10.1186/s13045-022-01387-0

Cite

Citations (27)

FAK regulates dynein localisation and cell polarity in migrating mouse fibroblasts

Biology of the Cell (2019)

Marta Fructuoso Marlène Legrand Antoine Mousson Tania Steffan Romain Vauchelles

Fibroblasts executing directional migration position their centrosome, and their Golgi apparatus, in front of the nucleus towards the cell leading edge. Centrosome positioning relative to the nucleus has been associated to mechanical forces exerted on the centrosome by the microtubule-dependent molecular motor cytoplasmic dynein 1, and to nuclear movements such as rearward displacement and rotation events. Dynein has been proposed to regulate the position of the centrosome by exerting pulling forces on microtubules from the cell leading edge, where the motor is enriched during migration. However, the mechanism explaining how dynein acts at the front of the cells has not been elucidated.We present here results showing that the protein Focal Adhesion Kinase (FAK) interacts with dynein and regulates the enrichment of the dynein/dynactin complex at focal adhesions at the cell the leading edge of migrating fibroblasts. This suggests that focal adhesions provide anchoring sites for dynein during the polarisation process. In support of this, we present evidence indicating that the interaction between FAK and dynein, which is regulated by the phosphorylation of FAK on its Ser732 residue, is required for proper centrosome positioning. Our results further show that the polarisation of the centrosome can occur independently of nuclear movements. Although FAK regulates both nuclear and centrosome motilities, downregulating the interaction between FAK and dynein affects only the nuclear independent polarisation of the centrosome.Our work highlights the role of FAK as a key player in the regulation of several aspects of cell polarity. We thus propose a model in which the transient localisation of dynein with focal adhesions provides a tuneable mechanism to bias dynein traction forces on microtubules allowing proper centrosome positioning in front of the nucleus.We unravel here a new role for the cancer therapeutic target FAK in the regulation of cell morphogenesis.

Dynactin

Microtubule organizing center

Astral microtubules

Cell polarity

10.1111/boc.201900041

Cite

Citations (6)

Protein dynamics at invadopodia control invasion–migration transitions in melanoma cells

Cell Death and Disease (2023)

Marlène Legrand Antoine Mousson Philippe Carl Léa Rossé Hélène Justiniano

Abstract Cell invasion is a highly complex process that requires the coordination of cell migration and degradation of the extracellular matrix. In melanoma cells, as in many highly invasive cancer cell types these processes are driven by the regulated formation of adhesives structures such as focal adhesions and invasive structures like invadopodia. Structurally, focal adhesion and invadopodia are quite distinct, yet they share many protein constituents. However, quantitative understanding of the interaction of invadopodia with focal adhesion is lacking, and how invadopodia turn-over is associated with invasion-migration transition cycles remains unknown. In this study, we investigated the role of Pyk2, cortactin and Tks5 in invadopodia turnover and their relation with focal adhesions. We found that active Pyk2 and cortactin are localised at both focal adhesions and invadopodia. At invadopodia, localisation of active Pyk2 is correlated with ECM degradation. During invadopodia disassembly, Pyk2 and cortactin but not Tks5 are often relocated at nearby nascent adhesions. We also show that during ECM degradation, cell migration is reduced which is likely related to the sharing of common molecules within the two structures. Finally, we found that the dual FAK/Pyk2 inhibitor PF-431396 inhibits both focal adhesion and invadopodia activities thereby reducing both migration and ECM degradation.

Invadopodia

Cortactin

Podosome

10.1038/s41419-023-05704-4

Cite

Citations (6)